Authors:
Beckmann, MW
Jap, D
Djahansouzi, S
Nestle-Kramling, C
Kuschel, B
Dall, P
Brumm, C
Bender, HG
Citation: Mw. Beckmann et al., Hormone replacement therapy after treatment of breast cancer: Effects on postmenopausal symptoms, bone mineral density and recurrence rates, ONCOL-BASEL, 60(3), 2001, pp. 199-206
Authors:
Muschen, M
Re, D
Betz, B
Moers, C
Wolf, J
Niederacher, D
Diehl, V
Beckmann, MW
Citation: M. Muschen et al., Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene, INT J CANC, 92(2), 2001, pp. 309-310
Authors:
Flototto, T
Djahansouzi, S
Glaser, M
Hanstein, B
Niederacher, D
Brumm, C
Beckmann, MW
Citation: T. Flototto et al., Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer, HORMONE MET, 33(8), 2001, pp. 451-457
Authors:
Glaeser, M
Floetotto, T
Hanstein, B
Beckmann, MW
Niederacher, D
Citation: M. Glaeser et al., Gene amplification and expression of the steroid receptor coactivator SRC3(AIB1) in sporadic breast and endometrial carcinomas, HORMONE MET, 33(3), 2001, pp. 121-126
Authors:
Kuschel, B
Lux, MP
Goecke, TO
Beckmann, MW
Citation: B. Kuschel et al., Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer, EUR J CAN P, 9(3), 2000, pp. 139-150
Authors:
Gerhardt, A
Scharf, RE
Beckmann, MW
Struve, S
Bender, HG
Pillny, M
Sandmann, W
Zotz, RB
Citation: A. Gerhardt et al., Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium., N ENG J MED, 342(6), 2000, pp. 374-380
Citation: M. Muschen et Mw. Beckmann, CD95 ligand expression as a criterion of malignant transformation in breast cancer, J PATHOLOGY, 191(4), 2000, pp. 468-469
Authors:
Beckmann, MW
Hanstein, B
Niederacher, D
Jap, D
Kuschel, B
Bender, HG
Citation: Mw. Beckmann et al., Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium, GEBURTSH FR, 60(2), 2000, pp. 71-76
Authors:
Beckmann, MW
Jap, D
Kuschel, B
Dall, P
Lux, MP
Hanstein, B
Bender, HG
Citation: Mw. Beckmann et al., Ovarian steroid hormones and anti-estrogens: Risks for and prevention of cancers of the breast and endometrium in the menopause, GEBURTSH FR, 60(2), 2000, pp. 77
Authors:
Mazoyer, S
Leary, J
Kirk, J
Fleischmann, E
Wagner, T
Claes, K
Messiaen, L
Foulkes, W
Desrochers, M
Simard, J
Phelan, CM
Kwan, E
Narod, SA
Vahteristo, P
Nevanlinna, H
Durando, X
Bignon, YJ
Peyrat, JP
Bonnardel, C
Sinilnikova, OM
Puget, N
Lenoir, GM
Mazoyer, S
Audoynaud, C
Goldgar, D
Maugard, C
Caux, V
Gad, S
Stoppa-Lyonnet, D
Nogues, C
Lidereau, R
Machavoine, C
Bressac-de Paillerets, B
Kuschel, B
Betz, B
Niederacher, D
Beckmann, MW
Hamann, U
Gayther, SA
Ponder, BAP
Robinson, M
Taylor, GR
Bishop, T
Catteau, A
Solomon, E
Cohen, B
Steel, M
Collins, N
Stratton, M
van der Looij, M
Olah, E
Miller, NJ
Barton, DE
Sverdlov, RS
Friedman, E
Radice, P
Montagna, M
Sensi, E
Caligo, M
van Eijk, R
Devilee, P
van der Luijt, R
Heimdal, K
Moller, P
Borg, A
Diez, O
Cortes, J
Domenech, M
Baiget, M
Osorio, A
Benitez, J
Borg, A
Maillet, P
Sappino, AP
Ozdag, H
Ozcelik, T
Ozturk, M
Rohlfs, EM
Boyd, J
McDermott, D
Offit, K
Unger, M
Nathanson, K
Weber, BL
Sellers, TA
Hampton, E
Couch, FJ
Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Authors:
Schmutzler, RK
Kempe, A
Kiechle, M
Beckmann, MW
Citation: Rk. Schmutzler et al., Clinical counselling and care of women with a genetic risk of ovarian and breast cancer, DEUT MED WO, 124(18), 1999, pp. 563-566
Authors:
Laake, K
Launonen, V
Niederacher, D
Gudlaugsdottir, S
Seitz, S
Rio, P
Champeme, MH
Bieche, I
Birnbaum, D
White, G
Sztan, M
Sever, N
Plummer, S
Osorio, A
Broeks, A
Huusko, P
Spurr, N
Borg, A
Cleton-Jansen, AM
van't Veer, L
Benitez, J
Casey, G
Peterlin, B
Olah, E
Varley, J
Bignon, YJ
Scherneck, S
Sigurdardottir, V
Lidereau, R
Eyfjord, J
Beckmann, MW
Winqvist, R
Skovlund, E
Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221